About this trial
This prospective observational case-control study aims to compare gingival crevicular fluid (GCF) biomarker profiles between children and young adults diagnosed with gingivitis. A total of approximately 80 systemically healthy participants will be recruited and divided into two groups: children aged 8-12 years and young adults aged 15-24 years. Individuals aged 13-14 years will be excluded as they represent a transitional pubertal period characterized by significant hormonal fluctuations that may influence inflammatory responses and confound biomarker levels.
Clinical periodontal parameters including gingival index, plaque index, bleeding on probing, and probing depth will be recorded. In addition, GCF samples will be collected from a standardized tooth and analyzed for levels of IL-1β, TNF-α, IL-10, and MMP-8 using enzyme-linked immunosorbent assay (ELISA).
The primary objective of the study is to evaluate and compare inflammatory and anti-inflammatory cytokine profiles between the two age groups. The findings may contribute to understanding age-related differences in gingival inflammatory responses and the potential role of hormonal transition in periodontal disease expression during childhood and early adulthood.
Eligibility criteria
Qualifiers
Individuals aged 8-12 years (child group) or 15-24 years (young adult group)
Clinical diagnosis of gingivitis
Presence of fully erupted tooth #31 with closed apex
Systemically healthy individuals
Disqualifiers
Age 13-14 years (transitional pubertal period)
Presence of periodontitis or other periodontal diseases
Systemic, genetic, or immunological diseases
Acute oral infections or conditions requiring emergency treatment
Trial design
Treatments tested in this trial
- Gingival Crevicular Fluid Biomarker Assessment